| 标题 |
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors |
| 网址 | |
| DOI |
10.1158/1078-0432.ccr-24-4280
doi
|
| 其它 |
期刊:Clinical Cancer Research 作者:Geoffrey Y. Ku; Lin Shen; Farshid Dayyani; Jeremy D. Kratz; Xinjun Liang; et al 出版日期:2025-06-26 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)